These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 29462689

  • 1. A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes.
    Shimizu T, Abu Lila AS, Fujita R, Awata M, Kawanishi M, Hashimoto Y, Okuhira K, Ishima Y, Ishida T.
    Eur J Pharm Biopharm; 2018 Jun; 127():142-149. PubMed ID: 29462689
    [Abstract] [Full Text] [Related]

  • 2. A Maleimide-Terminally Modified PEGylated Liposome Induced the Accelerated Blood Clearance Independent of the Production of Anti-PEG IgM Antibodies.
    Ishima Y, Yamazaki N, Chuang VTG, Shimizu T, Ando H, Ishida T.
    Biol Pharm Bull; 2022 Jun; 45(10):1518-1524. PubMed ID: 36184510
    [Abstract] [Full Text] [Related]

  • 3. The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage.
    Abu Lila AS, Kiwada H, Ishida T.
    J Control Release; 2013 Nov 28; 172(1):38-47. PubMed ID: 23933235
    [Abstract] [Full Text] [Related]

  • 4. Generation, characterization and in vivo biological activity of two distinct monoclonal anti-PEG IgMs.
    Hashimoto Y, Shimizu T, Mima Y, Abu Lila AS, Ishida T, Kiwada H.
    Toxicol Appl Pharmacol; 2014 May 15; 277(1):30-8. PubMed ID: 24632081
    [Abstract] [Full Text] [Related]

  • 5. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.
    Abu Lila AS, Nawata K, Shimizu T, Ishida T, Kiwada H.
    Int J Pharm; 2013 Nov 01; 456(1):235-42. PubMed ID: 23928149
    [Abstract] [Full Text] [Related]

  • 6. Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon.
    Shimizu T, Ishida T, Kiwada H.
    Immunobiology; 2013 May 01; 218(5):725-32. PubMed ID: 22995937
    [Abstract] [Full Text] [Related]

  • 7. Application of polyglycerol coating to plasmid DNA lipoplex for the evasion of the accelerated blood clearance phenomenon in nucleic acid delivery.
    Abu Lila AS, Uehara Y, Ishida T, Kiwada H.
    J Pharm Sci; 2014 Feb 01; 103(2):557-66. PubMed ID: 24347396
    [Abstract] [Full Text] [Related]

  • 8. Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein.
    Mima Y, Hashimoto Y, Shimizu T, Kiwada H, Ishida T.
    Mol Pharm; 2015 Jul 06; 12(7):2429-35. PubMed ID: 26070445
    [Abstract] [Full Text] [Related]

  • 9. Relationship between the concentration of anti-polyethylene glycol (PEG) immunoglobulin M (IgM) and the intensity of the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes in mice.
    Hashimoto Y, Shimizu T, Abu Lila AS, Ishida T, Kiwada H.
    Biol Pharm Bull; 2015 Jul 06; 38(3):417-24. PubMed ID: 25757923
    [Abstract] [Full Text] [Related]

  • 10. Ganglioside inserted into PEGylated liposome attenuates anti-PEG immunity.
    Mima Y, Abu Lila AS, Shimizu T, Ukawa M, Ando H, Kurata Y, Ishida T.
    J Control Release; 2017 Mar 28; 250():20-26. PubMed ID: 28179196
    [Abstract] [Full Text] [Related]

  • 11. Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes.
    Ishida T, Kiwada H.
    Int J Pharm; 2008 Apr 16; 354(1-2):56-62. PubMed ID: 18083313
    [Abstract] [Full Text] [Related]

  • 12. Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions.
    Kozma GT, Mészáros T, Vashegyi I, Fülöp T, Örfi E, Dézsi L, Rosivall L, Bavli Y, Urbanics R, Mollnes TE, Barenholz Y, Szebeni J.
    ACS Nano; 2019 Aug 27; 13(8):9315-9324. PubMed ID: 31348638
    [Abstract] [Full Text] [Related]

  • 13. Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes.
    Wang X, Ishida T, Kiwada H.
    J Control Release; 2007 Jun 04; 119(2):236-44. PubMed ID: 17399838
    [Abstract] [Full Text] [Related]

  • 14. Influence of phospholipid types and animal models on the accelerated blood clearance phenomenon of PEGylated liposomes upon repeated injection.
    Xu H, Ye F, Hu M, Yin P, Zhang W, Li Y, Yu X, Deng Y.
    Drug Deliv; 2015 Jun 04; 22(5):598-607. PubMed ID: 24524364
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pegfilgrastim (PEG-G-CSF) induces anti-PEG IgM in a dose dependent manner and causes the accelerated blood clearance (ABC) phenomenon upon repeated administration in mice.
    Elsadek NE, Lila ASA, Emam SE, Shimizu T, Takata H, Ando H, Ishima Y, Ishida T.
    Eur J Pharm Biopharm; 2020 Jul 04; 152():56-62. PubMed ID: 32376372
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Accelerated blood clearance (ABC) phenomenon induced by administration of PEGylated liposome].
    Ishida T, Kiwada H.
    Yakugaku Zasshi; 2008 Feb 04; 128(2):233-43. PubMed ID: 18239370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.